The impact of Coronavirus disease 2019 (COVID-19) pandemic on migraine disorder.

Haghdoost, Faraidoon; Carcel, Cheryl; Chandrasekhar, Deepak; Rodgers, Anthony; Delcourt, Candice

Haghdoost, Faraidoon; Carcel, Cheryl; Chandrasekhar, Deepak; Rodgers, Anthony; Delcourt, Candice.

Afiliación

Haghdoost F; The George Institute for Global Health, The University of New South Wales, Sydney, NSW, Australia.
Carcel C; The George Institute for Global Health, The University of New South Wales, Royal Prince Alfred Hospital, The University of Sydney, Sydney, NSW, Australia.
Chandrasekhar D; Healint Pte Ltd, Singapore, Singapore.
Rodgers A; The George Institute for Global Health, The University of New South Wales, Sydney, NSW, Australia.
Delcourt C; The George Institute for Global Health, The University of New South Wales, Sydney, NSW, Australia. cdelcourt@georgeinstitute.org.au.

J Neurol ; 268(12): 4429-4435, 2021 Dec.

Article en En | MEDLINE | ID: mdl-33950336

Asunto(s)

COVID-19; Trastornos Migrañosos; Adulto; Femenino; Cefalea; Humanos; Masculino; Persona de Mediana Edad; Trastornos Migrañosos/epidemiología; Pandemias; SARS-CoV-2

Palabras clave

Anxiety; COVID-19; Frequency; Headache; Migraine; Stress; Trigger

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Trastornos Migrañosos Tipo de estudio: Qualitative_research Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google